Founded in August 2004, Merck Research Laboratories (MRL) Boston is dedicated to discovering and developing medicines for cancer and neurodegenerative disorders. We utilize the most advanced technologies and share a team-oriented, accelerated approach to our research and innovation, thus transforming our drug development vision into reality. We are guided by an unwavering commitment to scientific excellence, high ethical standards and patient safety that dates back to Merck’s founding in 1891.

Located in the heart of Boston’s Longwood medical area, our state-of-the-art research facility is at the center of the emerging hub of premier biomedical research in North America. Our proximity to this world-renowned academic research community, leading hospitals and local biotechnology firms offers competitive advantages. Our alliances form an integral and vital part of our long-term business and research strategy. Our door is always open to collaboration, and MRL Boston is a first-choice research partner.

We also are a socially responsible neighbor and believe in supporting the community in which we live and work.  Through grants to researchers and academic institutions and through a variety of science education initiatives, we are fostering the growth of the next generation of scientists.